Drug Database
Back to search

Poland· PL-100401842

Agomelatine G.L. Pharma

A agomelatin product containing agomelatinum, registered in Poland by G.L. Pharma GmbH. The same ATC class is registered in 13 of our 19 countries.

ATC N06AX22

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAgomelatine G.L. PharmaATCN06AX22REGISTER NO.PL-100401842PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about agomelatinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Agomelatin is registered in 13 of 19 countries.

Countries holding a registration under ATC N06AX22 (agomelatin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search agomelatin products by name

Agomelatin · ATC N06AX22

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of agomelatin costs, country by country.

Normalised to the WHO defined daily dose (25 mg), the median price runs from $0.72 in France to $1.72 in Switzerland — a ×2.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Agomelatin · price per daily dose (25 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.72
  • FR France$0.72
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Agomelatinum
Manufacturer
G.L. Pharma GmbH
Country
Poland (PL)
ATC code
N06AX22
ATC class
Agomelatin
Defined daily dose
25 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • gtin
    09008732009293
    28 szt.
    PLN 62.13

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

25 interactions on record for agomelatin.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check agomelatin against other medicinesHow interaction checks work

Agomelatin · interactions on record

25 records

25 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Agomelatin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All agomelatin products

Authorised across Europe · EMA

The same active substance is authorised in 21 EEA countries. Names it is sold under:

  • Austria · Agogerolan, Agomelatin Genericon
  • Bulgaria · Агомелатин G.L. Pharma
  • Czechia · Agomelatin +pharma, Agomelatine G.L.Pharma
  • Germany · Agomaval, Agomelatin Abz
  • Denmark · Agomelatin Glenmark, Agomelatin Stada
  • Estonia · Lamegom
  • Spain · Agomelatina Aurovitas Spain, Agomelatina Qualigen
  • Finland · Agomelatine Stada, Agomelatine Viatris
  • France · Agomelatine Biogaran, Agomelatine Eg
  • United Kingdom (Northern Ireland) · Agomelatine Accord, Agomelatine Neuraxpharm
  • Hungary · Agomelatin Teva, Agomelatine Anpharm
  • Ireland · Agomelatine Viatris
  • Iceland · Agomelatine Stada, Valdoxan
  • Liechtenstein · Valdoxan
  • Lithuania · Agomelatine Anpharm, Lamegom
  • Malta · Agomaval
  • Netherlands · Agomaval, Agomelatine Accord
  • Norway · Valdoxan
  • Portugal · Agomelatina Ciclum, Agomelatina Generis
  • Sweden · Agomelatin Glenmark, Agomelatine Stada
  • Slovakia · Agomelatín Stada, Agomelatine G.L. Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b53320fa-6ffb-45c2-983c-5a9f393952f2
GET /v1/drugs/b53320fa-6ffb-45c2-983c-5a9f393952f2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "25 mg",
  "packaging": "09008732009293 ¦ Rp ¦ 131829\n28 tabl.",
  "substance": "Agomelatinum 25 mg",
  "common_name": "Agomelatinum",
  "pl_product_id": "100401842",
  "pozwolenie_nr": "25201",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about agomelatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console